Results 291 to 300 of about 165,965 (304)

GLUCAGON/GLP-1 RECEPTOR CO-AGONISTS

2008
DAY JONATHAN, PATTERSON JAMES, CHABENNE JOSEPH, DIMARCHI MARIA, SMILEY DAVID, DIMARCHI RICHARD D   +5 more
openaire   +8 more sources

Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists

Journal of the American College of Cardiology
Sebastiano Sciarretta, Beatrice Simeone   +1 more
exaly  

CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

2016
BIANCHI ELISABETTA, CARRINGTON PAUL E, DENG QIAOLIN, NARGUND RAVI, ORVIETO FEDERICA, PALANI ANANDAN, PESSI ANTONELLO, TUCKER THOMAS JOSEPH, WU CHENGWEI   +8 more
openaire   +5 more sources

Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists

Obesity Reviews
Ronald M Goldenberg, Sue D Pedersen, Julie Lovshin   +2 more
exaly  

GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation

Frontiers in Immunology
Giuseppe Privitera, Arianna Dal Buono, Cristina Bezzio   +2 more
exaly  

GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage

American Journal of Physiology - Heart and Circulatory Physiology
Javed Butler, Adrian Quan, Subodh Verma   +2 more
exaly  

GLP-1 receptor agonists in clinical practice

Medicina Clínica (English Edition)
openaire   +2 more sources

The GLP-1 Receptor Agonist Revolution

JACC
Stephen J. Nicholls, Adam J. Nelson
openaire   +1 more source

Glucagon/GLP-1 receptor co-agonists

2013
DIMARCHI RICHARD D, SMILEY DAVID L, YANG BIN S   +2 more
openaire   +3 more sources

GLP-1 RECEPTOR AGONISTS AND USES THEREOF

2019
ASPNES GARY ERIK, BAGLEY SCOTT W, CURTO JOHN M, EDMONDS DAVID JAMES, FLANAGAN MARK E, FUTATSUGI KENTARO, GRIFFITH DAVID A, HUARD KIM, LIAN YAJING, LIMBERAKIS CHRIS, LONDREGAN ALLYN T, MATHIOWETZ ALAN M, PIOTROWSKI DAVID W, RUGGERI ROGER B   +13 more
openaire   +6 more sources